Cibus, Inc.
corporate_fare Company Profile
Cibus, Inc. (NASDAQ:CBUS) is a publicly traded company in the Life Sciences sector. Wiseek monitors CBUS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- EU Regulatory Shift Opens Major Market for Cibus's Gene-Edited Crops
- Cibus Appoints Craig Wichner as CEO with $2.2M Equity Awards; Peter Beetham Returns to COO
- Cibus Registers 10.7M Shares for Potential Warrant Exercise, Enabling Up to $26.6M Capital Raise
- Cibus to Offer Up To $200M in Securities, Signaling Massive Dilution Risk
- Cibus Files $200M Universal Shelf and Establishes $50M ATM Program to Address Liquidity
Financial Snapshot
Dilution Risk
Moderate riskFiling-implied dilution signals for CBUS, detected from its recent SEC filings · based on capital-structure filings through 2026-05-22.
Potential Capital Raise · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →